- Home
- AUPH vs FLYW Comparison
AUPH vs FLYW Comparison
Compare AUPH & FLYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- FLYW
- Stock Information
- Founded
- AUPH 1993
- FLYW 2009
- Country
- AUPH Canada
- FLYW United States
- Employees
- AUPH N/A
- FLYW N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- FLYW Computer Software: Prepackaged Software
- Sector
- AUPH Health Care
- FLYW Technology
- Exchange
- AUPH Nasdaq
- FLYW Nasdaq
- Market Cap
- AUPH 1.4B
- FLYW 1.5B
- IPO Year
- AUPH 1999
- FLYW 2021
- Fundamental
- Price
- AUPH $11.47
- FLYW $13.03
- Analyst Decision
- AUPH Strong Buy
- FLYW Buy
- Analyst Count
- AUPH 2
- FLYW 14
- Target Price
- AUPH $13.00
- FLYW $14.38
- AVG Volume (30 Days)
- AUPH 1.9M
- FLYW 2.1M
- Earning Date
- AUPH 11-06-2025
- FLYW 11-06-2025
- Dividend Yield
- AUPH N/A
- FLYW N/A
- EPS Growth
- AUPH N/A
- FLYW N/A
- EPS
- AUPH 0.42
- FLYW 0.05
- Revenue
- AUPH $260,111,000.00
- FLYW $539,708,000.00
- Revenue This Year
- AUPH $17.33
- FLYW $20.22
- Revenue Next Year
- AUPH $14.31
- FLYW $15.73
- P/E Ratio
- AUPH $27.48
- FLYW $257.29
- Revenue Growth
- AUPH 25.59
- FLYW 22.20
- 52 Week Low
- AUPH $6.55
- FLYW $8.20
- 52 Week High
- AUPH $13.54
- FLYW $23.40
- Technical
- Relative Strength Index (RSI)
- AUPH 47.42
- FLYW 39.61
- Support Level
- AUPH $11.08
- FLYW $13.31
- Resistance Level
- AUPH $11.87
- FLYW $13.75
- Average True Range (ATR)
- AUPH 0.62
- FLYW 0.48
- MACD
- AUPH -0.14
- FLYW -0.12
- Stochastic Oscillator
- AUPH 44.06
- FLYW 31.38
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About FLYW Flywire Corporation Voting
Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements namely a payments platform; a proprietary payment network and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.